期刊文献+

血浆同型半胱氨酸水平与脑梗死并发2型糖尿病的相关研究 被引量:11

Study on plasma homocysteine (Hcy) levels in cerebral infarction complicated with type 2 diabetes Mellitus
下载PDF
导出
摘要 目的:探讨血浆同型半胱氨酸(Hcy)水平与动脉粥样硬化性血栓性脑梗塞合并2型糖尿病的关系。方法:选择动脉粥样硬化性血栓性脑梗塞合并2型糖尿病患者60例(A组)为患者组,动脉粥样硬化性血栓性脑梗塞无2型糖尿病病史患者60例(B组),2型糖尿病无动脉粥样硬化性血栓性脑梗塞60例(C组),健康人组60例(D组)B组、C组、D组均为对照组,用酶联免疫吸附法(ELISA)测定血浆同型半胱氨酸(Hcy)水平,用全自动生化分析仪检测总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDLC)、甘油三酯(TG),并进行统计分析。结果:A组Hcy高于B组、C组、D组,有显著性差异(P<0.05),B组Hcy值高于C组、D组,有显著性差异(P<0.05),C组高于D组(P<0.05),有显著性差异。结论:Hcy在动脉粥样硬化性血栓性脑梗塞合并2型糖尿病过程中起着协同作用,是动脉粥样硬化性血栓性脑梗塞合并2型糖尿病的重要危险因素。血浆Hcy的升高可能与动脉粥样硬化性血栓性脑梗塞合并2型糖尿病有相关性。 Objective: To investigate the relationship between plasma homocysteine (Hcy) levels and cere- bral infarction in patients with type 2 diabetes. Methods:240 people are divided into four groups: 60 cases of cerebral infarction in patients with type 2 diabetes (group A), simultaneous 60 cases of non-- diabetic patients with cerebral infarction(group B), 60 type 2 diabetes patients without cerebral infarction (Group C), and 60 healthy volunteers (group D). Determinations were examined by enzyme--linked immuno--sorbent assay (EL- SIA), and systematical analysis was made on the statistics of TC, LDL--C, HDLC, and TG. Results:Hcy of Group A is higher than Group B, C and D, showing a significant difference (P 〈 0.05), Hey of Group B is higher than Group C and D, with a significant difference (P 〈 0. 05). Hcy of Group C is higher than Group D (P 〈 0.05). Concl usion:Hcy in the pathogenesis of diabetic cerebral infarction plays a synergistic effect; there- fore, it is an important risk factor for diabetes complicated with cerebral infarction.
出处 《黑龙江医药科学》 2012年第3期13-14,共2页 Heilongjiang Medicine and Pharmacy
关键词 同型半胱氨酸 动脉粥样硬化性血栓性脑梗塞 2型糖尿病 homocysteine cerebral infarction type 2 diabetes
  • 相关文献

参考文献7

二级参考文献16

  • 1卜瑞芳,邓振霞,沈泓,许岚,吴懿玲,蒋艳敏,华嘉临,张稷.血浆同型半胱氨酸水平与2型糖尿病合并脑梗死的关系[J].中华内分泌代谢杂志,2004,20(5):444-445. 被引量:39
  • 2吴青,刘春风.血同型半胱氨酸水平与动脉粥样硬化性脑梗死的关系[J].苏州大学学报(医学版),2005,25(2):332-334. 被引量:8
  • 3张晖,樊东升.高同型半胱氨酸血症——脑卒中预防的新问题[J].中国全科医学,2005,8(22):1830-1831. 被引量:17
  • 4Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefit of increasing folic acid and intake[J].JAMA, 1995,274:1049.
  • 5Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project [J]. JAMA, 1997,39(22): 1390.
  • 6Munshi MN,Stone A, Fink L, et al. hyperhomocysteine following a methionone load in patients with non-insulin-dependent diabetes mellitus and microvascular disease[J]. Metabolism, 1996,45:133.
  • 7Hoffmann MA, Kohl B, Zumback MS, et al. Hyperhomocysteine and endothelial dysfunction in IDDM[J]. Diabetes Care,1997,20:1880.
  • 8Carlsen SM, Folling I, Grill V, et al. Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease[J]. Scand J Clin Lab Invest,1997,57:521.
  • 9Temple ME, Luzier AB, Kazierad DJ. Homocysteine as a risk factor for atherosclerosis[ J]. Ann Pharmacother,2000,34(1) :57-65.
  • 10Sasaki T,Watanabe M, Nagai Y,et al. Assaciation of plasm ahomocysteine concentration with atherosclerotic caroticl plaques and lacunar infarction [J] .Stroke,2002,33(15) : 1 493-1 496.

共引文献15772

同被引文献62

  • 1贾忠辉,李世军.高血压与肾脏疾病[J].肾脏病与透析肾移植杂志,2006,15(2):156-160. 被引量:5
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 3acques P,Ro:nberg H, Selhub .l,et al. Serum total homocysteine concenations in adolescent and aduh Americans: Results from the Third National Heal and Nutrition Examination Survey f J e[J]. AmJ C|in Nutr, 1999,69:482-489.
  • 4Hlavodee J, Sommereva Z, Pisarikova A, et al. Homocysteinemia andendothelial damage after nethionine load [J]. Thromb Res, 1997,88 : 361-364.
  • 5Tsai JC, Parrella MA, Yoshizumi M,et al. Promotion of vasen- larsmooth muscle celt:owth by homoeysteine:a link to atherosele- msis[J]. Proc Nail Acad Sei USA, 1994,91 (4) : 6369-6373.
  • 6Yamashina A,T om iyama H. A rterioscl erosi s and pulse wave ve- locity[J]. Nip pon Rinsho,2004, 62(1):80-86.
  • 7Graham IM, Daly LE,Reum HM,et al. Plasma homocysteine as a risk factorfor vascular disease. The European Conceaed Action Pro- ject [J]. JAMA, 1997,277 (22) : 1775-1781.
  • 8Hwang,SY,Siow,et al.Folio acid supple-mentation inhibita NADPH oxidase-mediated anion production in thekidney[J].Am J Phyaiol Renal Physiol,2011,300(1):189-198.
  • 9Jager A,Koetense PJ,Nijpels G,et al.Serum homocysteinelevels are associated with the development d(micro) album-inuria:The Hoorn Study[J].Arterioscler Thmmb Vasc Bio1,2007,21:74-81.
  • 10金意,鞠忠,乔大伟,张凤山,张永红.缺血性与出血性脑卒中危险因素对比分析[J].中国公共卫生,2008,24(3):285-286. 被引量:29

引证文献11

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部